Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vanda Pharmaceuticals Inc VNDA

Healthcare Biotechnology
Vanda Pharmaceuticals Inc. is a biopharmaceutical company, which is focused on the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. The Company’s commercial portfolio is comprised of three products: HETLIOZ for the treatment of non-24-hour sleep-wake disorder (Non-24) and for the treatment of nighttime sleep disturbances in... see more

Recent & Breaking News (NDAQ:VNDA)

UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of August 24, 2013 to Seek a Lead Plaintiff Position

PR Newswire August 6, 2013

Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA

Globe Newswire August 2, 2013

Key to Success, How to Profit: NOK, VNDA, AMAT and MDLZ

Marketwired July 31, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on AEGR, ARRY, VNDA and VRTX

Accesswire July 31, 2013

Vanda Pharmaceuticals Reports Second Quarter 2013 Results

PR Newswire July 31, 2013

Vanda Pharmaceuticals to Announce Second Quarter 2013 Financial Results on July 31, 2013

PR Newswire July 29, 2013

FDA Accepts Tasimelteon New Drug Application For Priority Review In The Treatment Of Non-24-Hour Disorder In The Totally Blind

PR Newswire July 29, 2013

UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of July 23, 2013 to Seek a Lead Plaintiff Position

Marketwired July 22, 2013

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA

Globe Newswire July 19, 2013

Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences

PR Newswire July 8, 2013

Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- VNDA

Globe Newswire July 7, 2013

Law Offices of Todd M. Garber Announces Investigation of Vanda Pharmaceuticals, Inc.

Business Wire July 3, 2013

Vanda Pharmaceuticals, Inc. Sued by Investor

PR Newswire July 3, 2013

Rigrodsky & Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Vanda Pharmaceuticals Inc.

Business Wire July 3, 2013

Vanda Pharmaceuticals Shareholder Alert: Briscoe Law and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors

Business Wire July 3, 2013

UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of July 23, 2013 to Seek a Lead Plaintiff Position -- VNDA

Globe Newswire July 2, 2013

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $150,000 From Investment in Vanda Pharmaceuticals, Inc. to Contact Brower Piven Before the August 26, 2013 Lead Plaintiff Deadline -- VNDA

Globe Newswire July 1, 2013

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Vanda Pharmaceuticals, Inc.

PR Newswire June 28, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on CNDO, NKTR, THRX and VNDA

Accesswire June 28, 2013

Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against Vanda Pharmaceuticals, Inc.

Business Wire June 27, 2013